Pine Valley Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$747K Sell
2,745
-6
-0.2% -$1.56K 0.03% 346
2026
Q2
$682K Sell
2,751
-173
-6% -$37.3K 0.03% 355
2026
Q1
$587K Sell
2,924
-319
-10% -$66K 0.03% 356
2025
Q4
$670K Sell
3,243
-144
-4% -$28.8K 0.03% 324
2025
Q3
$607K Sell
3,387
-260
-7% -$44.3K 0.03% 324
2025
Q2
$588K Buy
3,647
+8
+0.2% +$1.27K 0.03% 324
2025
Q1
$619K Buy
3,639
+6
+0.2% +$1.04K 0.04% 312
2024
Q4
$604K Buy
3,633
+150
+4% +$25.6K 0.04% 314
2024
Q3
$599K Buy
+3,483
New +$577K 0.04% 300
2024
Q2
– Sell
-3,342
Closed -$514K – 494
2024
Q1
$514K Buy
3,342
+39
+1% +$5.95K 0.03% 305
2023
Q4
$522K Buy
3,303
+46
+1% +$6.61K 0.04% 297
2023
Q3
$477K Sell
3,257
-14
-0.4% -$2.13K 0.04% 292
2023
Q2
$501K Sell
3,271
-1,308
-29% -$204K 0.05% 259
2023
Q1
$659K Buy
+4,579
New +$719K 0.1% 163

Other funds holding FBT

Pine Valley Investments's FBT Position: Q3 2026 in Review

Pine Valley Investments reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 0.22% in Q3 2026, selling an estimated $1.56K and leaving 2,745 shares worth $747K. The position accounts for 0.03% of the portfolio, ranked #346.

Pine Valley Investments first reported a position in FBT in Q1 2023 and has held it in 14 quarters since. 351 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Pine Valley Investments held 2,745 shares of First Trust NYSE Arca Biotechnology Index Fund worth $747K as of Q3 2026.
  • Pine Valley Investments sold 6 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $1.56K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Pine Valley Investments's portfolio in Q3 2026, its #346 holding.
  • Pine Valley Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and has held it in 14 quarters since.
  • 351 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Pine Valley Investments's 13F filing for Q3 2026, filed 9 Nov 2026.